anti-inflammatory effects of interleukin-4 are not mediated by suppressor of cytokine signalling-1 (SOCS1)

While it is known that the anti-inflammatory effects of interleukin (IL)-4 require new protein synthesis, the exact mechanisms by which IL-4 suppresses the production of pro-inflammatory cytokines by human monocytes and macrophages is unclear. IL-4 rapidly induced suppressor of cytokine signalling-1...

Full description

Saved in:
Bibliographic Details
Published inImmunology Vol. 131; no. 1; pp. 118 - 127
Main Authors Woodward, Eleanor A, Prêle, Cecilia M, Nicholson, Sandra E, Kolesnik, Tatiana B, Hart, Prue H
Format Journal Article
LanguageEnglish
Published Oxford, UK Oxford, UK : Blackwell Publishing Ltd 01.09.2010
Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Blackwell Science Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract While it is known that the anti-inflammatory effects of interleukin (IL)-4 require new protein synthesis, the exact mechanisms by which IL-4 suppresses the production of pro-inflammatory cytokines by human monocytes and macrophages is unclear. IL-4 rapidly induced suppressor of cytokine signalling-1 (SOCS1) mRNA and protein, which peaked at 60 min, much earlier than lipopolysaccharide (LPS)-induced SOCS1 mRNA and protein which were consistently maximal 4 hr post-exposure. SOCS1 is a molecule generally considered to be induced for negative feedback of inflammatory processes. We investigated whether the early induction of SOCS1 by IL-4 was responsible for the suppression of LPS-induced tumour necrosis factor (TNF)-α production by IL-4. IL-4 suppressed LPS-induced TNF-α in freshly isolated monocytes at the level of transcription but acted by a different, possibly translational, mechanism in monocytes cultured overnight in macrophage colony-stimulating factor (M-CSF). Despite different modes of regulation by IL-4, the kinetics and magnitude of induction of SOCS1 mRNA and protein by IL-4 in the two cell types were identical. There was no significant difference in the suppression by IL-4 of LPS-induced TNF-α production by bone-marrow derived macrophages from wild-type mice, Ifnγ⁻/⁻ mice and mice lacking SOCS1 (Socs1⁻/⁻Ifnγ⁻/⁻). These data suggest that SOCS1 is not involved in the suppression of LPS-induced TNF-α production by IL-4.
AbstractList While it is known that the anti‐inflammatory effects of interleukin (IL)‐4 require new protein synthesis, the exact mechanisms by which IL‐4 suppresses the production of pro‐inflammatory cytokines by human monocytes and macrophages is unclear. IL‐4 rapidly induced suppressor of cytokine signalling‐1 (SOCS1) mRNA and protein, which peaked at 60 min, much earlier than lipopolysaccharide (LPS)‐induced SOCS1 mRNA and protein which were consistently maximal 4 hr post‐exposure. SOCS1 is a molecule generally considered to be induced for negative feedback of inflammatory processes. We investigated whether the early induction of SOCS1 by IL‐4 was responsible for the suppression of LPS‐induced tumour necrosis factor (TNF)‐α production by IL‐4. IL‐4 suppressed LPS‐induced TNF‐α in freshly isolated monocytes at the level of transcription but acted by a different, possibly translational, mechanism in monocytes cultured overnight in macrophage colony‐stimulating factor (M‐CSF). Despite different modes of regulation by IL‐4, the kinetics and magnitude of induction of SOCS1 mRNA and protein by IL‐4 in the two cell types were identical. There was no significant difference in the suppression by IL‐4 of LPS‐induced TNF‐α production by bone‐marrow derived macrophages from wild‐type mice, Ifnγ −/− mice and mice lacking SOCS1 ( Socs1 −/− Ifnγ −/− ). These data suggest that SOCS1 is not involved in the suppression of LPS‐induced TNF‐α production by IL‐4.
Summary While it is known that the anti‐inflammatory effects of interleukin (IL)‐4 require new protein synthesis, the exact mechanisms by which IL‐4 suppresses the production of pro‐inflammatory cytokines by human monocytes and macrophages is unclear. IL‐4 rapidly induced suppressor of cytokine signalling‐1 (SOCS1) mRNA and protein, which peaked at 60 min, much earlier than lipopolysaccharide (LPS)‐induced SOCS1 mRNA and protein which were consistently maximal 4 hr post‐exposure. SOCS1 is a molecule generally considered to be induced for negative feedback of inflammatory processes. We investigated whether the early induction of SOCS1 by IL‐4 was responsible for the suppression of LPS‐induced tumour necrosis factor (TNF)‐α production by IL‐4. IL‐4 suppressed LPS‐induced TNF‐α in freshly isolated monocytes at the level of transcription but acted by a different, possibly translational, mechanism in monocytes cultured overnight in macrophage colony‐stimulating factor (M‐CSF). Despite different modes of regulation by IL‐4, the kinetics and magnitude of induction of SOCS1 mRNA and protein by IL‐4 in the two cell types were identical. There was no significant difference in the suppression by IL‐4 of LPS‐induced TNF‐α production by bone‐marrow derived macrophages from wild‐type mice, Ifnγ−/− mice and mice lacking SOCS1 (Socs1−/−Ifnγ−/−). These data suggest that SOCS1 is not involved in the suppression of LPS‐induced TNF‐α production by IL‐4.
While it is known that the anti-inflammatory effects of interleukin (IL)-4 require new protein synthesis, the exact mechanisms by which IL-4 suppresses the production of pro-inflammatory cytokines by human monocytes and macrophages is unclear. IL-4 rapidly induced suppressor of cytokine signalling-1 (SOCS1) mRNA and protein, which peaked at 60 min, much earlier than lipopolysaccharide (LPS)-induced SOCS1 mRNA and protein which were consistently maximal 4 hr post-exposure. SOCS1 is a molecule generally considered to be induced for negative feedback of inflammatory processes. We investigated whether the early induction of SOCS1 by IL-4 was responsible for the suppression of LPS-induced tumour necrosis factor (TNF)- alpha production by IL-4. IL-4 suppressed LPS-induced TNF- alpha in freshly isolated monocytes at the level of transcription but acted by a different, possibly translational, mechanism in monocytes cultured overnight in macrophage colony-stimulating factor (M-CSF). Despite different modes of regulation by IL-4, the kinetics and magnitude of induction of SOCS1 mRNA and protein by IL-4 in the two cell types were identical. There was no significant difference in the suppression by IL-4 of LPS-induced TNF- alpha production by bone-marrow derived macrophages from wild-type mice, Ifng--- mice and mice lacking SOCS1 (Socs1---Ifng---). These data suggest that SOCS1 is not involved in the suppression of LPS-induced TNF- alpha production by IL-4.
While it is known that the anti-inflammatory effects of interleukin (IL)-4 require new protein synthesis, the exact mechanisms by which IL-4 suppresses the production of pro-inflammatory cytokines by human monocytes and macrophages is unclear. IL-4 rapidly induced suppressor of cytokine signalling-1 (SOCS1) mRNA and protein, which peaked at 60 min, much earlier than lipopolysaccharide (LPS)-induced SOCS1 mRNA and protein which were consistently maximal 4 hr post-exposure. SOCS1 is a molecule generally considered to be induced for negative feedback of inflammatory processes. We investigated whether the early induction of SOCS1 by IL-4 was responsible for the suppression of LPS-induced tumour necrosis factor (TNF)-alpha production by IL-4. IL-4 suppressed LPS-induced TNF-alpha in freshly isolated monocytes at the level of transcription but acted by a different, possibly translational, mechanism in monocytes cultured overnight in macrophage colony-stimulating factor (M-CSF). Despite different modes of regulation by IL-4, the kinetics and magnitude of induction of SOCS1 mRNA and protein by IL-4 in the two cell types were identical. There was no significant difference in the suppression by IL-4 of LPS-induced TNF-alpha production by bone-marrow derived macrophages from wild-type mice, Ifngamma(-/-) mice and mice lacking SOCS1 (Socs1(-/-)Ifngamma(-/-)). These data suggest that SOCS1 is not involved in the suppression of LPS-induced TNF-alpha production by IL-4.
While it is known that the anti-inflammatory effects of interleukin (IL)-4 require new protein synthesis, the exact mechanisms by which IL-4 suppresses the production of pro-inflammatory cytokines by human monocytes and macrophages is unclear. IL-4 rapidly induced suppressor of cytokine signalling-1 (SOCS1) mRNA and protein, which peaked at 60 min, much earlier than lipopolysaccharide (LPS)-induced SOCS1 mRNA and protein which were consistently maximal 4 hr post-exposure. SOCS1 is a molecule generally considered to be induced for negative feedback of inflammatory processes. We investigated whether the early induction of SOCS1 by IL-4 was responsible for the suppression of LPS-induced tumour necrosis factor (TNF)-α production by IL-4. IL-4 suppressed LPS-induced TNF-α in freshly isolated monocytes at the level of transcription but acted by a different, possibly translational, mechanism in monocytes cultured overnight in macrophage colony-stimulating factor (M-CSF). Despite different modes of regulation by IL-4, the kinetics and magnitude of induction of SOCS1 mRNA and protein by IL-4 in the two cell types were identical. There was no significant difference in the suppression by IL-4 of LPS-induced TNF-α production by bone-marrow derived macrophages from wild-type mice, Ifnγ⁻/⁻ mice and mice lacking SOCS1 (Socs1⁻/⁻Ifnγ⁻/⁻). These data suggest that SOCS1 is not involved in the suppression of LPS-induced TNF-α production by IL-4.
Summary While it is known that the anti-inflammatory effects of interleukin (IL)-4 require new protein synthesis, the exact mechanisms by which IL-4 suppresses the production of pro-inflammatory cytokines by human monocytes and macrophages is unclear. IL-4 rapidly induced suppressor of cytokine signalling-1 (SOCS1) mRNA and protein, which peaked at 60 min, much earlier than lipopolysaccharide (LPS)-induced SOCS1 mRNA and protein which were consistently maximal 4 hr post-exposure. SOCS1 is a molecule generally considered to be induced for negative feedback of inflammatory processes. We investigated whether the early induction of SOCS1 by IL-4 was responsible for the suppression of LPS-induced tumour necrosis factor (TNF)-[alpha] production by IL-4. IL-4 suppressed LPS-induced TNF-[alpha] in freshly isolated monocytes at the level of transcription but acted by a different, possibly translational, mechanism in monocytes cultured overnight in macrophage colony-stimulating factor (M-CSF). Despite different modes of regulation by IL-4, the kinetics and magnitude of induction of SOCS1 mRNA and protein by IL-4 in the two cell types were identical. There was no significant difference in the suppression by IL-4 of LPS-induced TNF-[alpha] production by bone-marrow derived macrophages from wild-type mice, Ifn[gamma]-/- mice and mice lacking SOCS1 (Socs1-/-Ifn[gamma]-/-). These data suggest that SOCS1 is not involved in the suppression of LPS-induced TNF-[alpha] production by IL-4. [PUBLICATION ABSTRACT]
Author Woodward, Eleanor A
Hart, Prue H
Prêle, Cecilia M
Kolesnik, Tatiana B
Nicholson, Sandra E
Author_xml – sequence: 1
  fullname: Woodward, Eleanor A
– sequence: 2
  fullname: Prêle, Cecilia M
– sequence: 3
  fullname: Nicholson, Sandra E
– sequence: 4
  fullname: Kolesnik, Tatiana B
– sequence: 5
  fullname: Hart, Prue H
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20406299$$D View this record in MEDLINE/PubMed
BookMark eNqNks2P1CAYxolZ486u_gtK4kE9dOSzlIMmZuLHJrvZw7hnQlsYqS3MQqvb_17qrBP1olyAl9_z5IWHM3DigzcAQIzWOI_X3RrTkheEl2JNUK4iSiq8vnsAVseDE7BCCMuCVIifgrOUuryliPNH4JQghkoi5Qp02o-ucN72ehj0GOIMjbWmGRMMFjo_mtib6avzBYM6GujDCAfTOj2aFtYzTNN-H01KIS58M48hswYmt_O6753fFRi-3F5vtvjVY_DQ6j6ZJ_fzObj58P7z5lNxef3xYvPusmg4F7jQnNHG4JbqGtWYUGFlW4m6lTaXqxKR2tCyEgQLaXilueCUNLi1statlA2m5-DtwXc_1bnVxvgx6l7toxt0nFXQTv154t0XtQvfFJFlKUqWDV7cG8RwO5k0qsGlxvS99iZMSQnOOC2ZRP8mWSUZ4Yxk8vlfZBemmN8oKcxZiYRAaPGrDlQTQ0rR2GPXGKkledWpJWC1BKyW5NXP5NVdlj79_dZH4a-oM_DmAHx3vZn_21hdXF0tq6x_dtBbHZTeRZfUzZYsXwpXgnHE6Q85cse3
CitedBy_id crossref_primary_10_3233_JAD_170255
crossref_primary_10_1155_2017_4601959
crossref_primary_10_3389_fimmu_2022_1044249
crossref_primary_10_1007_s40618_022_01776_9
crossref_primary_10_3390_ijms241814221
crossref_primary_10_1080_09637486_2017_1288199
crossref_primary_10_1007_s12035_018_1016_x
crossref_primary_10_1038_s41551_023_01050_0
crossref_primary_10_1016_j_jep_2021_114003
crossref_primary_10_1055_a_2114_8333
crossref_primary_10_3389_fimmu_2023_1223817
crossref_primary_10_1007_s42978_022_00164_2
crossref_primary_10_1016_j_ejphar_2023_176058
crossref_primary_10_1055_a_1813_2057
crossref_primary_10_3390_ijms22168485
crossref_primary_10_1586_14760584_2016_1170598
crossref_primary_10_3389_fmed_2024_1337206
crossref_primary_10_3390_ijms21186546
crossref_primary_10_1088_1555_6611_aac29a
crossref_primary_10_1152_ajplung_00288_2022
crossref_primary_10_1016_j_ejphar_2022_175214
crossref_primary_10_1016_j_jff_2018_05_036
crossref_primary_10_3390_ani11040987
crossref_primary_10_1007_s13770_018_0147_5
crossref_primary_10_1016_j_jaci_2023_05_025
crossref_primary_10_1038_s41598_024_61909_3
crossref_primary_10_1038_s41598_024_51932_9
crossref_primary_10_1016_j_biomaterials_2021_121239
crossref_primary_10_1038_s41598_022_19401_3
crossref_primary_10_1080_08820139_2023_2186245
crossref_primary_10_2217_nnm_2018_0221
crossref_primary_10_1016_j_cyto_2012_03_009
crossref_primary_10_1097_MD_0000000000033439
crossref_primary_10_3390_ijms241814392
crossref_primary_10_4103_epj_epj_283_23
crossref_primary_10_1055_a_2181_1018
crossref_primary_10_1111_1750_3841_14168
crossref_primary_10_4161_viru_25641
crossref_primary_10_3390_nu11123000
crossref_primary_10_1007_s00018_022_04397_w
crossref_primary_10_1007_s10753_023_01843_0
crossref_primary_10_1002_JLB_3A0520_293RR
crossref_primary_10_3390_ph16020149
crossref_primary_10_3390_jcm12206519
crossref_primary_10_3390_metabo13010129
crossref_primary_10_1016_j_biotechadv_2018_07_004
crossref_primary_10_1189_jlb_1010557
crossref_primary_10_2174_2589977512999201109215004
Cites_doi 10.4049/jimmunol.173.2.737
10.1016/j.imbio.2008.07.015
10.4049/jimmunol.162.7.3770
10.1074/jbc.273.44.29202
10.1038/nature03988
10.1016/S0092-8674(00)80047-1
10.4049/jimmunol.177.5.3028
10.1016/S0167-4889(96)00107-3
10.1146/annurev.immunol.021908.132532
10.1002/(SICI)1521-4141(199805)28:05<1719::AID-IMMU1719>3.0.CO;2-Q
10.4049/jimmunol.177.6.3520
10.1038/nri978
10.1074/jbc.270.16.9558
10.1189/jlb.71.6.1026
10.1016/j.cmet.2008.04.003
10.3109/08977190109001087
10.1016/S0022-1759(03)00229-1
10.1002/art.1780371202
10.1016/0167-5699(96)10029-3
10.1152/ajpendo.90632.2008
10.1073/pnas.95.24.14395
10.1074/jbc.272.22.14394
10.1016/j.pharmthera.2009.06.011
10.1038/nature05894
10.4049/jimmunol.171.11.5901
10.1038/nm804
10.1016/S1074-7613(02)00446-6
10.1038/34184
10.1146/annurev.immunol.17.1.701
10.1159/000053271
10.1159/000028096
10.1073/pnas.86.10.3803
10.1074/jbc.M102737200
10.1002/eji.200636910
10.1002/jlb.57.6.909
10.4049/jimmunol.160.8.4048
10.1074/jbc.M509595200
10.4049/jimmunol.146.10.3431
10.1126/science.8332913
10.1016/S1074-7613(02)00449-1
10.4049/jimmunol.156.7.2591
10.4049/jimmunol.180.8.5257
10.1074/jbc.M707442200
10.1038/sj.gene.6364352
10.2174/156802609788085250
10.1084/jem.20080452
10.1074/jbc.M409825200
10.4049/jimmunol.151.10.5603
10.1074/jbc.272.15.10212
10.1074/jbc.C500053200
10.1172/JCI115872
10.4049/jimmunol.181.11.8018
10.1074/jbc.M006227200
10.4049/jimmunol.149.4.1283
10.1073/pnas.96.19.10800
10.4049/jimmunol.163.8.4546
ContentType Journal Article
Copyright 2010 The Authors. Journal Compilation © 2010 Blackwell Publishing Ltd
Journal compilation © 2010 Blackwell Publishing Ltd
Copyright_xml – notice: 2010 The Authors. Journal Compilation © 2010 Blackwell Publishing Ltd
– notice: Journal compilation © 2010 Blackwell Publishing Ltd
DBID FBQ
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7QR
7T5
7U9
8FD
C1K
FR3
H94
M7N
P64
7X8
5PM
DOI 10.1111/j.1365-2567.2010.03281.x
DatabaseName AGRIS
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Bacteriology Abstracts (Microbiology B)
Chemoreception Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Virology and AIDS Abstracts
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Immunology Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList CrossRef


AIDS and Cancer Research Abstracts
MEDLINE

Virology and AIDS Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1365-2567
EndPage 127
ExternalDocumentID 3378166291
10_1111_j_1365_2567_2010_03281_x
20406299
IMM3281
US201301874505
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OC
24P
29I
2WC
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
A8Z
AAESR
AAEVG
AAHHS
AAJUZ
AAKAS
AANLZ
AAONW
AASGY
AAVGM
AAXRX
AAZKR
ABCQN
ABCUV
ABCVL
ABDBF
ABEML
ABHUG
ABJNI
ABPTK
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACNCT
ACPOU
ACPRK
ACSCC
ACXBN
ACXME
ACXQS
ADAWD
ADBBV
ADBTR
ADDAD
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFDAS
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFVGU
AFZJQ
AGJLS
AIACR
AIAGR
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
AOIJS
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EAS
EBB
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EPT
ESTFP
ESX
EX3
F00
F01
F04
F5P
FBQ
FD6
FIJ
FUBAC
G-S
G.N
GODZA
GX1
H.X
HF~
HZI
HZ~
H~9
IH2
IHE
IPNFZ
IX1
J0M
J5H
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MVM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OBC
OBS
OHT
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
Q~Q
R.K
ROL
RPM
RX1
SUPJJ
SV3
TEORI
TR2
TUS
UB1
UPT
V8K
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOQ
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
Y6R
YF5
YFH
YOC
YUY
ZA5
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AHBTC
AITYG
HGLYW
OIG
CGR
CUY
CVF
ECM
EIF
NPM
AAMNL
AAYXX
CITATION
7QL
7QR
7T5
7U9
8FD
C1K
FR3
H94
M7N
P64
7X8
5PM
ID FETCH-LOGICAL-c5571-a543ce1d3ab0b1237f9d87bd9f3ce8602be36872179e58a57532c1df9bad99c13
IEDL.DBID RPM
ISSN 0019-2805
IngestDate Tue Sep 17 21:22:08 EDT 2024
Wed Dec 04 04:08:14 EST 2024
Wed Dec 04 07:05:30 EST 2024
Thu Oct 10 20:04:01 EDT 2024
Fri Nov 22 00:51:04 EST 2024
Sat Sep 28 08:16:16 EDT 2024
Sat Aug 24 00:57:08 EDT 2024
Wed Dec 27 19:28:50 EST 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5571-a543ce1d3ab0b1237f9d87bd9f3ce8602be36872179e58a57532c1df9bad99c13
Notes http://dx.doi.org/10.1111/j.1365-2567.2010.03281.x
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966764
PMID 20406299
PQID 1546077000
PQPubID 37820
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2966764
proquest_miscellaneous_754536490
proquest_miscellaneous_748942542
proquest_journals_1546077000
crossref_primary_10_1111_j_1365_2567_2010_03281_x
pubmed_primary_20406299
wiley_primary_10_1111_j_1365_2567_2010_03281_x_IMM3281
fao_agris_US201301874505
PublicationCentury 2000
PublicationDate September 2010
PublicationDateYYYYMMDD 2010-09-01
PublicationDate_xml – month: 09
  year: 2010
  text: September 2010
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: England
– name: Oxford
PublicationTitle Immunology
PublicationTitleAlternate Immunology
PublicationYear 2010
Publisher Oxford, UK : Blackwell Publishing Ltd
Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Blackwell Science Inc
Publisher_xml – name: Oxford, UK : Blackwell Publishing Ltd
– name: Blackwell Publishing Ltd
– name: Wiley Subscription Services, Inc
– name: Blackwell Science Inc
References 2002; 17
1998; 160
1993; 23
1989; 86
1996; 1314
1997; 272
1999; 162
2008; 7
1992; 15
2003; 278
2006; 177
2007; 37
1998; 273
1992; 90
1991; 146
1999; 17
2000; 54
2004; 173
2003; 9
2007; 8
2001; 19
2003; 3
1999; 98
2009; 124
1994; 37
1999; 96
2006; 281
1998; 95
1995; 163
1998; 28
1996; 17
2007; 447
1995; 57
2005; 437
2009; 297
1999; 67
2003; 171
2008; 205
2000; 275
1992; 76
2009; 27
1996; 10
2008; 283
1995; 270
2001; 276
2008; 181
2008; 180
2005; 280
1998; 391
2004; 279
2009; 9
1993; 151
2002; 71
2008; 213
1996; 156
18926294 - Immunobiology. 2008;213(9-10):789-803
9826711 - Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14395-9
15849198 - J Biol Chem. 2005 Jun 24;280(25):23496-501
2786204 - Proc Natl Acad Sci U S A. 1989 May;86(10):3803-7
18390706 - J Immunol. 2008 Apr 15;180(8):5257-66
15489227 - J Biol Chem. 2004 Dec 31;279(53):55633-43
1322938 - J Clin Invest. 1992 Aug;90(2):382-8
7986216 - Arthritis Rheum. 1994 Dec;37(12):1715-22
19017994 - J Immunol. 2008 Dec 1;181(11):8018-26
11595817 - Horm Res. 2000;54(5-6):275-80
10490099 - Cell. 1999 Sep 3;98(5):597-608
12050189 - J Leukoc Biol. 2002 Jun;71(6):1026-32
10982806 - J Biol Chem. 2000 Dec 1;275(48):38095-103
16920939 - J Immunol. 2006 Sep 1;177(5):3028-34
12957395 - J Immunol Methods. 2003 Jul;278(1-2):45-56
16473883 - J Biol Chem. 2006 Apr 21;281(16):11135-43
12433365 - Immunity. 2002 Nov;17(5):583-91
9558115 - J Immunol. 1998 Apr 15;160(8):4048-56
8982276 - Biochim Biophys Acta. 1996 Dec 12;1314(3):226-32
17183610 - Eur J Immunol. 2007 Jan;37(1):14-6
10358772 - Annu Rev Immunol. 1999;17:701-38
12433373 - Immunity. 2002 Nov;17(5):677-87
19105661 - Annu Rev Immunol. 2009;27:451-83
8854561 - Immunol Today. 1996 Sep;17(9):424-8
9786931 - J Biol Chem. 1998 Oct 30;273(44):29202-9
8786324 - J Immunol. 1996 Apr 1;156(7):2591-8
18852293 - J Exp Med. 2008 Oct 27;205(11):2595-608
8332913 - Science. 1993 Jul 23;261(5120):472-5
12461524 - Nat Med. 2003 Jan;9(1):40-6
1328039 - Immunology. 1992 Aug;76(4):560-5
9162077 - J Biol Chem. 1997 May 30;272(22):14394-8
14634100 - J Immunol. 2003 Dec 1;171(11):5901-7
16951310 - J Immunol. 2006 Sep 15;177(6):3520-4
19417127 - Am J Physiol Endocrinol Metab. 2009 Jul;297(1):E174-83
2026872 - J Immunol. 1991 May 15;146(10):3431-6
7540642 - J Leukoc Biol. 1995 Jun;57(6):909-18
16127449 - Nature. 2005 Sep 29;437(7059):759-63
10201892 - J Immunol. 1999 Apr 1;162(7):3770-4
1386862 - J Immunol. 1992 Aug 15;149(4):1283-8
17981803 - J Biol Chem. 2008 Jan 25;283(4):1808-17
17093501 - Genes Immun. 2007 Jan;8(1):21-7
9603479 - Eur J Immunol. 1998 May;28(5):1719-26
11306591 - J Biol Chem. 2001 Jun 22;276(25):22086-9
11811777 - Growth Factors. 2001;19(4):207-18
15240659 - J Immunol. 2004 Jul 15;173(2):737-46
17515919 - Nature. 2007 Jun 28;447(7148):1116-20
18522831 - Cell Metab. 2008 Jun;7(6):496-507
9092569 - J Biol Chem. 1997 Apr 11;272(15):10212-9
10485906 - Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10800-5
9422509 - Nature. 1998 Jan 1;391(6662):82-6
19615407 - Pharmacol Ther. 2009 Nov;124(2):141-50
8709636 - Leukemia. 1996 Aug;10(8):1308-16
12511873 - Nat Rev Immunol. 2003 Jan;3(1):23-35
10725788 - Pathobiology. 1999;67(5-6):222-6
10510398 - J Immunol. 1999 Oct 15;163(8):4546-56
19355993 - Curr Top Med Chem. 2009;9(3):309-19
8228249 - J Immunol. 1993 Nov 15;151(10):5603-12
7721885 - J Biol Chem. 1995 Apr 21;270(16):9558-63
e_1_2_7_5_2
Dokter WH (e_1_2_7_20_2) 1996; 10
e_1_2_7_9_2
e_1_2_7_7_2
e_1_2_7_17_2
e_1_2_7_15_2
Takeshita S (e_1_2_7_35_2) 1996; 156
e_1_2_7_13_2
e_1_2_7_41_2
e_1_2_7_43_2
e_1_2_7_45_2
e_1_2_7_47_2
e_1_2_7_49_2
e_1_2_7_28_2
Donnelly RP (e_1_2_7_18_2) 1991; 146
e_1_2_7_50_2
e_1_2_7_25_2
e_1_2_7_52_2
e_1_2_7_31_2
e_1_2_7_54_2
e_1_2_7_21_2
e_1_2_7_33_2
e_1_2_7_56_2
e_1_2_7_58_2
Bonder CS (e_1_2_7_37_2) 1998; 160
e_1_2_7_39_2
Lubberts E (e_1_2_7_11_2) 1995; 163
Fenton MJ (e_1_2_7_3_2) 1992; 15
e_1_2_7_4_2
e_1_2_7_2_2
e_1_2_7_8_2
e_1_2_7_6_2
e_1_2_7_16_2
e_1_2_7_14_2
e_1_2_7_40_2
e_1_2_7_12_2
e_1_2_7_42_2
e_1_2_7_10_2
e_1_2_7_44_2
e_1_2_7_46_2
Losman JA (e_1_2_7_23_2) 1999; 162
e_1_2_7_48_2
e_1_2_7_27_2
Hart PH (e_1_2_7_26_2) 1992; 76
e_1_2_7_29_2
Donnelly RP (e_1_2_7_19_2) 1993; 151
e_1_2_7_24_2
e_1_2_7_30_2
e_1_2_7_51_2
e_1_2_7_22_2
e_1_2_7_32_2
e_1_2_7_53_2
e_1_2_7_34_2
e_1_2_7_55_2
e_1_2_7_36_2
e_1_2_7_57_2
e_1_2_7_38_2
e_1_2_7_59_2
References_xml – volume: 270
  start-page: 9558
  year: 1995
  end-page: 63
  article-title: Interleukin (IL)‐10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL‐10 and IL‐4 suppress cytokine synthesis by different mechanisms
  publication-title: J Biol Chem
– volume: 17
  start-page: 701
  year: 1999
  end-page: 38
  article-title: The IL‐4 receptor: signaling mechanisms and biologic functions
  publication-title: Annu Rev Immunol
– volume: 171
  start-page: 5901
  year: 2003
  end-page: 7
  article-title: IL‐4 and IL‐13 induce SOCS‐1 gene expression in A549 cells by three functional STAT6‐binding motifs located upstream of the transcription initiation site
  publication-title: J Immunol
– volume: 71
  start-page: 1026
  year: 2002
  end-page: 32
  article-title: Post‐transcriptional regulation of TNF‐alpha during in vitro differentiation of human monocytes/macrophages in primary culture
  publication-title: J Leukoc Biol
– volume: 151
  start-page: 5603
  year: 1993
  end-page: 12
  article-title: Tissue‐specific regulation of IL‐6 production by IL‐4. Differential effects of IL‐4 on nuclear factor‐kappa B activity in monocytes and fibroblasts
  publication-title: J Immunol
– volume: 19
  start-page: 207
  year: 2001
  end-page: 18
  article-title: Characterization of IL‐4 receptor components expressed on monocytes and monocyte‐derived macrophages: variation associated with differential signaling by IL‐4
  publication-title: Growth Factors
– volume: 1314
  start-page: 226
  year: 1996
  end-page: 32
  article-title: Interleukin‐4 blocks the release of collagen fragments from bovine nasal cartilage treated with cytokines
  publication-title: Biochim Biophys Acta
– volume: 17
  start-page: 424
  year: 1996
  end-page: 8
  article-title: Heterogeneity of human blood monocytes: the CD14 CD16 subpopulation
  publication-title: Immunol Today
– volume: 9
  start-page: 40
  year: 2003
  end-page: 6
  article-title: Interleukin‐4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease
  publication-title: Nat Med
– volume: 181
  start-page: 8018
  year: 2008
  end-page: 26
  article-title: SOCS1 regulates the IFN but not NFkappaB pathway in TLR‐stimulated human monocytes and macrophages
  publication-title: J Immunol
– volume: 37
  start-page: 14
  year: 2007
  end-page: 6
  article-title: New vistas on macrophage differentiation and activation
  publication-title: Eur J Immunol
– volume: 281
  start-page: 11135
  year: 2006
  end-page: 43
  article-title: The comparative roles of suppressor of cytokine signaling‐1 and ‐3 in the inhibition and desensitization of cytokine signaling
  publication-title: J Biol Chem
– volume: 180
  start-page: 5257
  year: 2008
  end-page: 66
  article-title: Polarization of primary human monocytes by IFN‐gamma induces chromatin changes and recruits RNA Pol II to the TNF‐alpha promoter
  publication-title: J Immunol
– volume: 146
  start-page: 3431
  year: 1991
  end-page: 6
  article-title: IL‐1 expression in human monocytes is transcriptionally and posttranscriptionally regulated by IL‐4
  publication-title: J Immunol
– volume: 177
  start-page: 3520
  year: 2006
  end-page: 4
  article-title: TREM‐2 attenuates macrophage activation
  publication-title: J Immunol
– volume: 90
  start-page: 382
  year: 1992
  end-page: 8
  article-title: Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin‐4
  publication-title: J Clin Invest
– volume: 76
  start-page: 560
  year: 1992
  end-page: 5
  article-title: Interleukin‐4 suppression of monocyte tumour necrosis factor‐alpha production. Dependence on protein synthesis but not on cyclic AMP production
  publication-title: Immunology
– volume: 98
  start-page: 597
  year: 1999
  end-page: 608
  article-title: SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine
  publication-title: Cell
– volume: 156
  start-page: 2591
  year: 1996
  end-page: 8
  article-title: Differential regulation of IL‐6 gene transcription and expression by IL‐4 and IL‐10 in human monocytic cell lines
  publication-title: J Immunol
– volume: 297
  start-page: E174
  year: 2009
  end-page: 83
  article-title: PPAR‐γ inhibits NF‐κB‐dependent transcriptional activation in skeletal muscle
  publication-title: Am J Physiol Endocrinol Metab
– volume: 447
  start-page: 1116
  year: 2007
  end-page: 20
  article-title: Macrophage‐specific PPARgamma controls alternative activation and improves insulin resistance
  publication-title: Nature
– volume: 279
  start-page: 55633
  year: 2004
  end-page: 43
  article-title: Constitutive and interleukin‐1‐inducible phosphorylation of p65 NF‐κB at serine 536 is mediated by multiple protein kinases including IκB kinase (IKK)‐α, IKKβ, IKKε, TRAF family member‐associated (TANK)‐binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA‐binding protein‐associated factor II31‐mediated interleukin‐8 transcription
  publication-title: J Biol Chem
– volume: 276
  start-page: 22086
  year: 2001
  end-page: 9
  article-title: Suppressor of cytokine signaling‐1 attenuates the duration of interferon gamma signal transduction in vitro and in vivo
  publication-title: J Biol Chem
– volume: 273
  start-page: 29202
  year: 1998
  end-page: 9
  article-title: STAT6 is required for the anti‐inflammatory activity of interleukin‐4 in mouse peritoneal macrophages
  publication-title: J Biol Chem
– volume: 95
  start-page: 14395
  year: 1998
  end-page: 9
  article-title: Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling‐1
  publication-title: Proc Natl Acad Sci USA
– volume: 173
  start-page: 737
  year: 2004
  end-page: 46
  article-title: Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling
  publication-title: J Immunol
– volume: 86
  start-page: 3803
  year: 1989
  end-page: 7
  article-title: Potential anti‐ inflammatory effects of interleukin‐4. Suppression of human monocyte TNFα, IL‐1 and PGE2 levels
  publication-title: Proc Natl Acad Sci USA
– volume: 3
  start-page: 23
  year: 2003
  end-page: 35
  article-title: Alternative activation of macrophages
  publication-title: Nat Rev Immunol
– volume: 391
  start-page: 82
  year: 1998
  end-page: 6
  article-title: PPAR‐gamma agonists inhibit production of monocyte inflammatory cytokines
  publication-title: Nature
– volume: 162
  start-page: 3770
  year: 1999
  end-page: 4
  article-title: Cutting edge: SOCS‐1 is a potent inhibitor of IL‐4 signal transduction
  publication-title: J Immunol
– volume: 124
  start-page: 141
  year: 2009
  end-page: 50
  article-title: Emerging roles of peroxisome proliferator‐activated receptor‐beta/delta in inflammation
  publication-title: Pharmacol Ther
– volume: 9
  start-page: 309
  year: 2009
  end-page: 19
  article-title: Histone deacetylase inhibitors in inflammatory disease
  publication-title: Curr Top Med Chem
– volume: 54
  start-page: 275
  year: 2000
  article-title: Regulation of macrophage gene expression by the peroxisome proliferator‐activated receptor‐gamma
  publication-title: Horm Res
– volume: 163
  start-page: 4546
  year: 1995
  end-page: 56
  article-title: Adenoviral vector‐mediated overexpression of IL‐4 in the knee joint of mice with collagen‐induced arthritis prevents cartilage destruction
  publication-title: J Immunol
– volume: 8
  start-page: 21
  year: 2007
  end-page: 7
  article-title: Suppressor of cytokine signaling‐1 is an IL‐4‐inducible gene in macrophages and feedback inhibits IL‐4 signaling
  publication-title: Genes Immun
– volume: 67
  start-page: 222
  year: 1999
  end-page: 6
  article-title: Alternative versus classical activation of macrophages
  publication-title: Pathobiology
– volume: 17
  start-page: 677
  year: 2002
  end-page: 87
  article-title: SOCS‐1 participates in negative regulation of LPS responses
  publication-title: Immunity
– volume: 27
  start-page: 451
  year: 2009
  end-page: 83
  article-title: Alternative activation of macrophages: an immunologic functional perspective
  publication-title: Annu Rev Immunol
– volume: 272
  start-page: 14394
  year: 1997
  end-page: 8
  article-title: Interleukin‐4 and ‐13 inhibit tumor necrosis factor‐alpha mRNA translational activation in lipopolysaccharide‐induced mouse macrophages
  publication-title: J Biol Chem
– volume: 17
  start-page: 583
  year: 2002
  end-page: 91
  article-title: SOCS‐1/JAB is a negative regulator of LPS‐induced macrophage activation
  publication-title: Immunity
– volume: 275
  start-page: 38095
  year: 2000
  end-page: 103
  article-title: Interleukin‐4/STAT6 represses STAT1 and NF‐kappa B‐dependent transcription through distinct mechanisms
  publication-title: J Biol Chem
– volume: 205
  start-page: 2595
  year: 2008
  end-page: 608
  article-title: Tuning sensitivity to IL‐4 and IL‐13: differential expression of IL‐4Ralpha, IL‐13Ralpha1, and gammac regulates relative cytokine sensitivity
  publication-title: J Exp Med
– volume: 28
  start-page: 1719
  year: 1998
  end-page: 26
  article-title: IL‐10‐mediated suppression of TNF‐alpha production is independent of its ability to inhibit NF kappa B activity
  publication-title: Eur J Immunol
– volume: 272
  start-page: 10212
  year: 1997
  end-page: 9
  article-title: Interleukin‐4 suppression of tumor necrosis factor alpha‐stimulated E‐selectin gene transcription is mediated by STAT6 antagonism of NF‐kappaB
  publication-title: J Biol Chem
– volume: 177
  start-page: 3028
  year: 2006
  end-page: 34
  article-title: Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model
  publication-title: J Immunol
– volume: 57
  start-page: 909
  year: 1995
  end-page: 18
  article-title: Monocytes cultured in cytokine‐defined environments differ from freshly isolated monocytes in their responses to IL‐4 and IL‐10
  publication-title: J Leukoc Biol
– volume: 37
  start-page: 1715
  year: 1994
  end-page: 22
  article-title: Interleukin‐4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis
  publication-title: Arthritis Rheum
– volume: 10
  start-page: 1308
  year: 1996
  end-page: 16
  article-title: Effects of IL‐10 and IL‐4 on LPS‐induced transcription factors (AP‐1, NF‐IL6 and NF‐kappa B) which are involved in IL‐6 regulation
  publication-title: Leukemia
– volume: 280
  start-page: 23496
  year: 2005
  end-page: 501
  article-title: Bruton’s tyrosine kinase is involved in p65‐mediated transactivation and phosphorylation of p65 on serine 536 during NFkappaB activation by lipopolysaccharide
  publication-title: J Biol Chem
– volume: 96
  start-page: 10800
  year: 1999
  end-page: 5
  article-title: Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS‐1 gene expression
  publication-title: Proc Natl Acad Sci USA
– volume: 15
  start-page: 1283
  year: 1992
  end-page: 8
  article-title: IL‐4 reciprocally regulates IL‐1 and IL‐1 receptor antagonist expression in human monocytes
  publication-title: J Immunol
– volume: 278
  start-page: 45
  year: 2003
  end-page: 56
  article-title: Centrifugation facilitates transduction of green fluorescent protein in human monocytes and macrophages by adenovirus at low multiplicity of infection
  publication-title: J Immunol Methods
– volume: 7
  start-page: 496
  year: 2008
  end-page: 507
  article-title: Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity‐induced insulin resistance
  publication-title: Cell Metab
– volume: 283
  start-page: 1808
  year: 2008
  end-page: 17
  article-title: A pivotal role for interleukin‐4 in atorvastatin‐associated neuroprotection in rat brain
  publication-title: J Biol Chem
– volume: 437
  start-page: 759
  year: 2005
  end-page: 63
  article-title: A SUMOylation‐dependent pathway mediates transrepression of inflammatory response genes by PPAR‐gamma
  publication-title: Nature
– volume: 160
  start-page: 4048
  year: 1998
  end-page: 56
  article-title: Involvement of the IL‐2 receptor gamma‐chain (gammac) in the control by IL‐4 of human monocyte and macrophage proinflammatory mediator production
  publication-title: J Immunol
– volume: 23
  start-page: 472
  year: 1993
  end-page: 5
  article-title: Interleukin‐1 type II receptor: a decoy target for IL‐1 that is regulated by IL‐4
  publication-title: Science
– volume: 213
  start-page: 789
  year: 2008
  end-page: 803
  article-title: The many faces of PPARgamma: anti‐inflammatory by any means?
  publication-title: Immunobiology
– ident: e_1_2_7_24_2
  doi: 10.4049/jimmunol.173.2.737
– ident: e_1_2_7_52_2
  doi: 10.1016/j.imbio.2008.07.015
– volume: 162
  start-page: 3770
  year: 1999
  ident: e_1_2_7_23_2
  article-title: Cutting edge: SOCS‐1 is a potent inhibitor of IL‐4 signal transduction
  publication-title: J Immunol
  doi: 10.4049/jimmunol.162.7.3770
  contributor:
    fullname: Losman JA
– ident: e_1_2_7_36_2
  doi: 10.1074/jbc.273.44.29202
– ident: e_1_2_7_56_2
  doi: 10.1038/nature03988
– ident: e_1_2_7_28_2
  doi: 10.1016/S0092-8674(00)80047-1
– ident: e_1_2_7_14_2
  doi: 10.4049/jimmunol.177.5.3028
– ident: e_1_2_7_6_2
  doi: 10.1016/S0167-4889(96)00107-3
– ident: e_1_2_7_15_2
  doi: 10.1146/annurev.immunol.021908.132532
– ident: e_1_2_7_16_2
  doi: 10.1002/(SICI)1521-4141(199805)28:05<1719::AID-IMMU1719>3.0.CO;2-Q
– ident: e_1_2_7_42_2
  doi: 10.4049/jimmunol.177.6.3520
– ident: e_1_2_7_9_2
  doi: 10.1038/nri978
– ident: e_1_2_7_34_2
  doi: 10.1074/jbc.270.16.9558
– ident: e_1_2_7_45_2
  doi: 10.1189/jlb.71.6.1026
– ident: e_1_2_7_59_2
  doi: 10.1016/j.cmet.2008.04.003
– ident: e_1_2_7_38_2
  doi: 10.3109/08977190109001087
– ident: e_1_2_7_41_2
  doi: 10.1016/S0022-1759(03)00229-1
– ident: e_1_2_7_7_2
  doi: 10.1002/art.1780371202
– ident: e_1_2_7_43_2
  doi: 10.1016/0167-5699(96)10029-3
– ident: e_1_2_7_57_2
  doi: 10.1152/ajpendo.90632.2008
– ident: e_1_2_7_27_2
  doi: 10.1073/pnas.95.24.14395
– ident: e_1_2_7_17_2
  doi: 10.1074/jbc.272.22.14394
– ident: e_1_2_7_54_2
  doi: 10.1016/j.pharmthera.2009.06.011
– ident: e_1_2_7_58_2
  doi: 10.1038/nature05894
– ident: e_1_2_7_22_2
  doi: 10.4049/jimmunol.171.11.5901
– ident: e_1_2_7_12_2
  doi: 10.1038/nm804
– volume: 10
  start-page: 1308
  year: 1996
  ident: e_1_2_7_20_2
  article-title: Effects of IL‐10 and IL‐4 on LPS‐induced transcription factors (AP‐1, NF‐IL6 and NF‐kappa B) which are involved in IL‐6 regulation
  publication-title: Leukemia
  contributor:
    fullname: Dokter WH
– ident: e_1_2_7_31_2
  doi: 10.1016/S1074-7613(02)00446-6
– ident: e_1_2_7_53_2
  doi: 10.1038/34184
– ident: e_1_2_7_21_2
  doi: 10.1146/annurev.immunol.17.1.701
– ident: e_1_2_7_55_2
  doi: 10.1159/000053271
– ident: e_1_2_7_8_2
  doi: 10.1159/000028096
– ident: e_1_2_7_2_2
  doi: 10.1073/pnas.86.10.3803
– ident: e_1_2_7_29_2
  doi: 10.1074/jbc.M102737200
– ident: e_1_2_7_10_2
  doi: 10.1002/eji.200636910
– ident: e_1_2_7_40_2
  doi: 10.1002/jlb.57.6.909
– volume: 160
  start-page: 4048
  year: 1998
  ident: e_1_2_7_37_2
  article-title: Involvement of the IL‐2 receptor gamma‐chain (gammac) in the control by IL‐4 of human monocyte and macrophage proinflammatory mediator production
  publication-title: J Immunol
  doi: 10.4049/jimmunol.160.8.4048
  contributor:
    fullname: Bonder CS
– ident: e_1_2_7_33_2
  doi: 10.1074/jbc.M509595200
– volume: 146
  start-page: 3431
  year: 1991
  ident: e_1_2_7_18_2
  article-title: IL‐1 expression in human monocytes is transcriptionally and posttranscriptionally regulated by IL‐4
  publication-title: J Immunol
  doi: 10.4049/jimmunol.146.10.3431
  contributor:
    fullname: Donnelly RP
– ident: e_1_2_7_4_2
  doi: 10.1126/science.8332913
– ident: e_1_2_7_30_2
  doi: 10.1016/S1074-7613(02)00449-1
– volume: 156
  start-page: 2591
  year: 1996
  ident: e_1_2_7_35_2
  article-title: Differential regulation of IL‐6 gene transcription and expression by IL‐4 and IL‐10 in human monocytic cell lines
  publication-title: J Immunol
  doi: 10.4049/jimmunol.156.7.2591
  contributor:
    fullname: Takeshita S
– ident: e_1_2_7_51_2
  doi: 10.4049/jimmunol.180.8.5257
– ident: e_1_2_7_13_2
  doi: 10.1074/jbc.M707442200
– ident: e_1_2_7_25_2
  doi: 10.1038/sj.gene.6364352
– ident: e_1_2_7_50_2
  doi: 10.2174/156802609788085250
– volume: 76
  start-page: 560
  year: 1992
  ident: e_1_2_7_26_2
  article-title: Interleukin‐4 suppression of monocyte tumour necrosis factor‐alpha production. Dependence on protein synthesis but not on cyclic AMP production
  publication-title: Immunology
  contributor:
    fullname: Hart PH
– ident: e_1_2_7_44_2
  doi: 10.1084/jem.20080452
– ident: e_1_2_7_49_2
  doi: 10.1074/jbc.M409825200
– volume: 151
  start-page: 5603
  year: 1993
  ident: e_1_2_7_19_2
  article-title: Tissue‐specific regulation of IL‐6 production by IL‐4. Differential effects of IL‐4 on nuclear factor‐kappa B activity in monocytes and fibroblasts
  publication-title: J Immunol
  doi: 10.4049/jimmunol.151.10.5603
  contributor:
    fullname: Donnelly RP
– ident: e_1_2_7_47_2
  doi: 10.1074/jbc.272.15.10212
– ident: e_1_2_7_48_2
  doi: 10.1074/jbc.C500053200
– ident: e_1_2_7_5_2
  doi: 10.1172/JCI115872
– ident: e_1_2_7_32_2
  doi: 10.4049/jimmunol.181.11.8018
– ident: e_1_2_7_46_2
  doi: 10.1074/jbc.M006227200
– volume: 15
  start-page: 1283
  year: 1992
  ident: e_1_2_7_3_2
  article-title: IL‐4 reciprocally regulates IL‐1 and IL‐1 receptor antagonist expression in human monocytes
  publication-title: J Immunol
  doi: 10.4049/jimmunol.149.4.1283
  contributor:
    fullname: Fenton MJ
– ident: e_1_2_7_39_2
  doi: 10.1073/pnas.96.19.10800
– volume: 163
  start-page: 4546
  year: 1995
  ident: e_1_2_7_11_2
  article-title: Adenoviral vector‐mediated overexpression of IL‐4 in the knee joint of mice with collagen‐induced arthritis prevents cartilage destruction
  publication-title: J Immunol
  doi: 10.4049/jimmunol.163.8.4546
  contributor:
    fullname: Lubberts E
SSID ssj0013055
Score 2.255998
Snippet While it is known that the anti-inflammatory effects of interleukin (IL)-4 require new protein synthesis, the exact mechanisms by which IL-4 suppresses the...
Summary While it is known that the anti‐inflammatory effects of interleukin (IL)‐4 require new protein synthesis, the exact mechanisms by which IL‐4 suppresses...
While it is known that the anti‐inflammatory effects of interleukin (IL)‐4 require new protein synthesis, the exact mechanisms by which IL‐4 suppresses the...
Summary While it is known that the anti-inflammatory effects of interleukin (IL)-4 require new protein synthesis, the exact mechanisms by which IL-4 suppresses...
SourceID pubmedcentral
proquest
crossref
pubmed
wiley
fao
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 118
SubjectTerms Animals
Anti-Inflammatory Agents - metabolism
Anti-Inflammatory Agents - pharmacology
Cells, Cultured
Cytokines
endotoxin/lipopolysaccharide
Humans
inflammation
Interferon-gamma - pharmacology
Interleukin-4 - metabolism
Interleukin-4 - pharmacology
Lipopolysaccharides - immunology
Lipopolysaccharides - pharmacology
Macrophages - drug effects
Macrophages - immunology
Macrophages - metabolism
macrophages/monocytes
Medical research
Mice
Mice, Inbred C57BL
Monocytes - drug effects
Monocytes - immunology
Monocytes - metabolism
Original
Proteins
RNA, Messenger - genetics
RNA, Messenger - metabolism
Rodents
Signal Transduction
signalling/signal transduction
Suppressor of Cytokine Signaling 1 Protein
Suppressor of Cytokine Signaling Proteins - drug effects
Suppressor of Cytokine Signaling Proteins - genetics
Suppressor of Cytokine Signaling Proteins - metabolism
Tumor Necrosis Factor-alpha - metabolism
SummonAdditionalLinks – databaseName: Wiley Online Library - Core collection (SURFmarket)
  dbid: DR2
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nj9MwEB3BSiAufCwfG1iQDxzgkKqOnTg-ooXVglSQKJX2ZtmJA1UhWbWJRDnxE_iN_BJmnLRsYYUQ4lbVdtRM3sw81y8zAI9thdsqn_hYOq9iKWUVW-nKWJSYILxNpfCh2ufr7GQmX52mp4P-id6F6etDbP9wI88I8Zoc3LrVrpMHhVaaqUGhJZKcj4hPcqFI3ff8bfLzQGGcDs0MdJzk43RX1HPhhXYy1eXKNheR0N-1lOc5bkhSxzdgsbm9XpuyGHWtGxVffqn8-H_u_yZcH7gse9aD7xZc8vU-XOm7W6734epkOLe_DS2ikeEznH__-g0hjSj8FE732SAnYU3FqHDF8qPvFvMaZ0lml57VTcvCuy3Ii5lbs1V3FoS7zZJWFOu2wdmekQjFhuLiuJKzJ9M3R1P-9A7Mjl-8OzqJh34PcZGmiseEjMLzUlg3dphRVaXLXLlSV_g19cpyXmQ5blmV9mlukWiKpOBlpZ0ttS64uAt7dVP7A2C-yHHrneOQsFJaKkKvMTLlpfUlx0UR8M2zNWd9WQ9zbjuEhjVkWEOGNcGw5nMEBwgCY99j9DWzaUKgoo6GyCEjONwgwwwxYGWQnGZjpTDnRMC2w-i9dCRja990K0O1fzBqyuQPU5DjikxqvMq9HmrbX5xgBM6QT0SgdkC4nUC1w3dH6vmHUEM80SRulhFkAWN_bQTzcjKhT_f_deEDuNYLMEimdwh77bLzD5HXte5R8NgfwAxAQg
  priority: 102
  providerName: Wiley-Blackwell
Title anti-inflammatory effects of interleukin-4 are not mediated by suppressor of cytokine signalling-1 (SOCS1)
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1365-2567.2010.03281.x
https://www.ncbi.nlm.nih.gov/pubmed/20406299
https://www.proquest.com/docview/1546077000
https://search.proquest.com/docview/748942542
https://search.proquest.com/docview/754536490
https://pubmed.ncbi.nlm.nih.gov/PMC2966764
Volume 131
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD5aJ4F4QWxcFhiTH3iAB6-1YyfxI6rYBlIBUSr1zbITZ1SsSdWLRP89x05SVm1CiJcoip2LfI59viN_-Q7AG1NiWuW4o8K6lAohSmqELWhcYIBwRorYBbXPz8nVRHyayukByO5fmEDaz-3svLqZn1ezH4FbuZjn_Y4n1v86GnLlmZmi34Meht8uRe-2DgayLVugKM8Gcp--E0hdMklbUlfMMxa0qDk6c8KDAuyf8NQrTX0f8rxLoLwNbENkungCj1tISd43n34EB646hgdNkcntMTwctdvnT6FCpyA4lDOKfoWuMA9b7KTldJC6JF49YnnjNj9nFRXELB2p6jUJv5cgNCV2S1abReDO1kvfP9-ua-zriOeBmKDvTRl5O_4yHLN3z2By8eH78Iq2BRdoLmXKqDdN7lgRGzuwGNLSUhVZagtV4mVfrMq6OMkwZ0yVk5lBpBfznBWlsqZQKmfxczis6sqdAHF5hrlvhk2xEcJ4FXiFS0NWGFcwvCkC1o2zXjS6GvpWPoJm0t5M2ptJBzPpXxGcoEG0ucblT0_G3NvalxREEBfBaWcl3U7ClUZ0mAzSFBf9CMiuGaeP3xMxlas3K-3Fd3DZEvwvXRBkxolQ-JQXjdl3X9x5TQTpnkPsOnjx7v0W9Okg4t36cARJcJ1_HgT9cTTyZy__-5Wv4FFDgfBEuVM4XC837jUiq7U9w5ziG8fj5ZSdhVn1G0scHMU
link.rule.ids 230,314,727,780,784,885,1375,27924,27925,46294,46718,53791,53793
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEB5BEZQLj_KoocAeOMDBUdZeP_aIClUKTZFII_W22rXXELW1q8SWCCd-Ar-RX8LM2gk1VAghblF210rG38x86_08A_BcF7itsoH1hbGJL4QofC1M7oc5JgirIxFaV-3zMB5Nxdvj6LhrB0TvwrT1IdYP3MgzXLwmB6cH0n0vdxKtKE46iVYYpHyAhPIaej8nfdfrD8HPI4Vh1LUzkH6QDqO-rOfSK_Vy1dVCV5fR0N_VlBdZrktTe7fhdPUHW3XKyaCpzSD78kvtx_9kgTtwq6Oz7FWLv7twxZZbcL1tcLncghvj7uj-HtQISIa3cfb96zdENQLxzB3ws05RwqqCUe2K-altTmYlzhJMzy0rq5q511uQGjOzZIvm3Gl3qzmtyJZ1hbMtIx2KdvXFcSVnLybvdyf85X2Y7r052h35XcsHP4uihPsEjszyPNRmaDCpJoXM08TkssCvqV2WsWGc4q41kTZKNXLNMMh4XkijcykzHj6AjbIq7TYwm6W4-05xKNRCaKpDLzE4pbm2OcdFHvDVzVXnbWUPdWFHhIZVZFhFhlXOsOqzB9uIAqU_YgBW00lAqKKmhkgjPdhZQUN1YWChkJ_GwyTBtOMBWw-jA9OpjC5t1SwUlf_BwCmCP0xBmhvGQuJVHrZYW__iAINwjJTCg6SHwvUEKh_eHylnn1wZ8UCSvll4EDuQ_bUR1P54TJ8e_evCZ7A5OhofqIP9w3eP4WarxyDV3g5s1PPGPkGaV5unzn1_AMa8RGM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9NAEB1BERWXAoVSQ4E9cICDo3i9_tgjaolaIAURIvW2WnvXEAXsKHGkhhM_gd_IL2Fm7YQaKoQQtyi7ayXjNx_rfX4D8EQXuK2y3Pois4kvhCh8LTLjhwYThNWRCK1T-zyNj8fi5Vl01vKf6F2YRh9i88CNPMPFa3LwmSm6Tu4YWlGctAytkKdBD-vJayLmknT0j97xnycK_ajtZiB9nvajLqvn0it1UtXVQleXVaG_kykvFrkuSw1uwnT9_xpyyrS3rLNe_uUX6cf_Y4BbsNMWs-x5g77bcMWWu3C9aW-52oXtYXtwfwdqhCPDmzj5_vUbYhph-Nkd77OWT8KqgpFyxfyTXU4nJc4STM8tK6uauZdbsDBm2YotljPH3K3mtCJf1RXOtoxYKNqpi-PKgD0dvTkcBc_uwnjw4v3hsd82fPDzKEoCn6CR28CEOutnmFKTQpo0yYws8GtqlpXZME5xz5pIG6UaK82Q54EpZKaNlHkQ7sFWWZV2H5jNU9x7pzgUaiE0qdBLDE2p0dYEuMiDYH1v1azR9VAX9kNoWEWGVWRY5Qyrzj3YRxAo_QHDrxqPOIGKWhpiEenBwRoZqg0CC4XVadxPEkw6HrDNMLovncno0lbLhSLxHwybgv9hCha5YSwkXuVeA7XNL-YYghHr0oOkA8LNBBIP746Uk49ORJxLYjcLD2KHsb82gjoZDunT_X9d-Bi23x4N1OuT01cP4EZDxiDK3gFs1fOlfYg1Xp09cs77A7bXQxI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+anti-inflammatory+effects+of+interleukin-4+are+not+mediated+by+suppressor+of+cytokine+signalling-1+%28SOCS1%29&rft.jtitle=Immunology&rft.au=Woodward%2C+Eleanor+A&rft.au=Pr%C3%AAle%2C+Cecilia+M&rft.au=Nicholson%2C+Sandra+E&rft.au=Kolesnik%2C+Tatiana+B&rft.date=2010-09-01&rft.eissn=1365-2567&rft.volume=131&rft.issue=1&rft.spage=118&rft_id=info:doi/10.1111%2Fj.1365-2567.2010.03281.x&rft_id=info%3Apmid%2F20406299&rft.externalDocID=20406299
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0019-2805&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0019-2805&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0019-2805&client=summon